Quantitative autoradiographic visualization and pharmacology of FP- prostaglandin receptors in human eyes using the novel phosphor-imaging technology

Journal of Ocular Pharmacology and Therapeutics

Volumn 15, Issue 4, 1999, Pages 323-336

  Davis, T L ^a   Sharif, N A ^a  

^a ALCON RESEARCH LTD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPROSTENOL; FLUPROSTENOL; LATANOPROST; PHOSPHORUS; PHXA 85; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN RECEPTOR; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; TRITIUM; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; CILIARY MUSCLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DENSITOMETRY; DRUG POTENCY; EYE; FEMALE; HUMAN; HUMAN TISSUE; IMAGING; MALE; PHARMACOLOGY; RETINA; SPHINCTER PUPILLAE MUSCLE;

EID: 0032838343     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.1999.15.323     Document Type: Article

References (43)

1. 2α. Arch. Ophthalmol. 105:1112-1116, 1987.
2. Hellberg, M.R., Sallee, V.L., McLaughlin, M.A., Sharif, N.A., DeSantis, L., Dean, T.R. and Zinke, P.W. Preclinical efficacy of AL-6221, a potent and selective FP prostaglandin agonist. Invest. Ophthalmol. Vis. Sci. 39 (#4, Suppl):Abst. # 1961, 1998.
3. Sallee, V.L., McLaughlin, M.A., Griffin, B.W. and Sharif, N.A. Correlation of results from preclinical experimental models used for evaluation of FP prostaglandin agonists for therapy of glaucoma Invest. Ophthalmol. Vis. Sci. 39 (#4, Suppl):Abst. # 4274, 1998.
4. 2α increases uveoscleral outflow in the cynomolgus monkey. Exp. Eye Res. 49:389-402, 1989.
5. 2α on intraocular pressure in normotensive human subjects. Invest. Ophthalmol. Vis. Sci. 29:1474-1477, 1988.
6. Bito, L.Z. Prostaglandins: a new approach to glaucoma management with a new intriguing side-effect. Surv. Ophthalmol. 41 (suppl. 22):S1-S14, 1997.
7. 2α-1-isopropylester in the cynomolgus monkey. Exp. Eye Res. 48:707-716, 1989.
8. Goh, Y., Hotehama, Y. and Mishima, H.K. Characterization of ciliary muscle relaxation induced by various agents in cats. Invest. Ophthalmol. Vis. Sci. 36:1188-1192, 1995.
9. Weinreb, R.N., Kashiwagi, K., Kashiwagi, F., Tsukahara, S. and Lindsey, J.D. Prostaglandins increase matrix metalloproteinase release from human ciliary smooth muscle cells. Invest. Ophthalmol. Vis. Sci. 38:2770-2772, 1997.
10. 2α and its analogs induce release of endogenous prostaglandins in iris and ciliary muscles isolated from cat and other mammalian species. Expt. Eye Res. 63:305-310, 1996.
11. 2α binding sites in the bovine iris ciliary body. Invest. Ophthalmol. Vis. Sci. 34:2237-2245, 1993.
12. Bhattacherjee, P. and Paterson, C.A. Studies on prostanoid receptors in ocular tissues. J. Ocular Pharmacol. 10:167-175, 1994.
13. Sharif, N.A. Quantitative autoradiographic methods. In Brain mapping: the methods, Toga, A.W. and Mazziota, J.C., eds., Academic Press Inc., New York, 1996, pp. 115-144.
14. 2 receptor subtypes in porcine ocular tissues. I. uveal tissues. J. Ocular Pharmacol. Ther. 11:421-435, 1995.
15. 2α receptor messenger RNA and protein in the cynomolgus monkey eye. Invest. Ophthalmol. Vis. Sci. 37: 716-726, 1996.
16. 2 receptor is the predominant prostanoid receptor in the human ciliary muscle. Br. J. Ophthalmol. 77:110-114, 1993.
17. Upham, L.V. and Englert, D.F. Radionucleide imaging. In Handbook of Radionucleide Analysis, L'Lannunziata, M., ed., Academic Press, New York, Chap. 11, 1998, pp. 637-692.
18. Sharif, N.A. and Hughes, J. Discrete mapping of brain mu and delta opioid receptors using selective peptides: quantitative autoradiography, species differences and comparison with kappa receptors. Peptides 10:499-522, 1989.
19. Sharif, N.A. and Eglen, R.M. Quantitative autoradiography: a tool to visualize and quantify receptors, enzymes, transporters, and second messenger systems. In Molecular Imaging in Neuroscience, Sharif, N.A., ed., Oxford University Press, 1993, pp. 71-138.
20. 3 and FP receptor binding sites in bovine corpus luteum: characterization and correlation with functional data. J. Pharmacol. Expt. Ther. 286:1094-1102, 1998.
21. 3H]GR65630 binding. Br. J. Pharmacol. 102:919-925, 1991.
22. 1-selective antagonist for ocular use. Receptor binding and second messenger studies. J. Ocular Pharmacol. 10:653-664, 1994.
23. Chegini, N., Lei, Z.M., Rao, Ch.V. and Hansel, W. Cellular distribution and cycle phase dependency of gonadotropin and eicosanoid binding sites in bovine corpora lutea. Biol. Reproduction 45:506-513, 1991.
24. 2, and their esters in glaucomatous monkey eyes. Invest. Ophthalmol. Vis. Sci. 31:2466-2470, 1990.
25. Sakurai, M., Araie, M., Oshika, T., Mori, M., Shoji, N. and Masuda, K. Effects of topical application of UF-021, a novel prostaglandin-related compound, on aqueous humor dynamics in rabbit. Jpn. J. Ophthalmol. 37:252-258, 1993.
26. Goh, Y. and Kishino, J. Pharmacological characterization of prostaglandin-related ocular hypotensive agents. Jpn. J. Ophthalmol. 38:236-245, 1994.
27. 2α analogue. Adv. Prostaglandin Thrombox. Leukotr. Res. 23:513-518, 1995.
28. 2α analog, on aqueous humor dynamics in human eyes. Ophthalmology 100:1297-1304, 1993.
29. 2α in the human eye. Graefes Arch. Clin. Exp. Ophthalmol. 222:139-141, 1985.
30. Coleman, R.A., Smith, W.L. and Narumiya, S. VIII International Union of Pharmacology classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev. 46:205-229, 1994.
31. Chen, J., Champa-Rodriguez, M.L. and Woodward, D.F. Identification of a prostanoid FP receptor population producing endothelium-dependent vasorelaxation in the rabbit jugular vein. Br. J. Pharmacol. 116:3035-3041, 1995.
32. Senior, J., Marshall, K., Sangha, R. and Clayton, J.K. In vitro characterization of prostanoid receptors on human myometrium at term pregnancy. Br. J. Pharmacol. 108:501-506, 1993.
33. Powell, W.S., Hammarstrom, S., Samuelsson, B., Miller, W.L., Sun, F.F., Fried, J., Lin, C.H. and Jarabak, J. Interaction between prostaglandin analogues and a receptor in bovine corpora lutea. Correlation of dissociation constants with luteolytic potencies in hamsters. Eur. J. Biochem. 59:271-276, 1975.
34. Griffin, B.W., Williams, G.W., Crider, J.Y. and Sharif, N.A. FP prostaglandin receptors mediating inositol phosphate generation and calcium mobilization in Swiss 3T3 cells: a pharmacological study. J. Pharmacol. Expt. Ther. 281:845-854, 1997.
35. Griffin, B.W., Magnino, P.E., Pang, I-H. and Sharif, N.A. Pharmacological characterization of an FP prostaglandin receptor on rat vascular smooth muscle cells (A7r5) coupled to phosphoinositide turnover and intracellular calcium mobilization. J. Pharmacol. Expt. Ther. 286:411-418, 1998.
36. Niswender, G.D. and Nett, T.M. Corpus luteum and its control. In The Physiology of Reproduction, Knobll, E. and Neil, J., eds., Raven Press, New York, 1988, pp. 489-525.
37. 2α receptor. J. Biol. Chem. 269:3881-3886, 1994.
38. Chen, W., Andon, T., Bhattacherjee, P. and Paterson, C. Intracellular calcium mobilization following prostaglandin receptor activation in human ciliary muscle cells. Curr. Eye Res. 16:847-853, 1997.
39. 3H]9-β-[+]fluprostenol): carboxylic acid of travoprost (AL-6221), a novel FP-prostaglandin to study the pharmacology and autoradiographic location of the FP receptor. J. Pharm. Pharmacol. (in press, 1999).
40. Abdel-Latif, A. A. Phosphoinositide and arachidonic acid signalling systems in the mammalian iris. Prog. Retinal Eye Res. 14:75-107, 1995.
41. Bhattacherjee, P. and Paterson, C.A. Studies on prostanoid receptors in ocular tissues. J. Ocular Pharmacol. 10:167-175, 1994.
42. Sharif, N.A., Wiernas, T.K., Howe, W.E., Griffin, B.W., Offord, E.A. and Pfeifer, A.M.A. Human corneal epithelial cell functional responses to inflammatory agents and their antagonists. Invest. Ophthalmol. Vis. Sci. 39:2562-2571, 1998.
43. 2α on the comeal and intraretinal d.c. electroretinogram (ERG) of the albino rabbit eye. Curr. Eye Res. 14:1073-1080, 1995.